Skip to main content
NCBI home page
Scientific Reports logoLink to Scientific Reports
. 2019 Nov 29;9:17876. doi: 10.1038/s41598-019-54188-w

Construction of miRNA-target networks using microRNA profiles of CVB3-infected HeLa cells

Hai Lan Yao 1,#, Mi Liu 2,3,#, Wen Jun Wang 2,3, Xin Ling Wang 2,3, Juan Song 2,3, Qin Qin Song 2,3, Jun Han 2,3,✉
PMCID: PMC6884461  PMID: 31784561

Abstract

MicroRNAs (miRNAs) play an important role in regulating gene expression in multiple biological processes and diseases. Thus, to understand changes in miRNA during CVB3 infection, specific miRNA expression profiles were investigated at 3 h, 6 h, and 9 h postinfection in HeLa cells by small-RNA high-throughput sequencing. Biological implications of 68 differentially expressed miRNAs were analyzed through GO and KEGG pathways. Interaction networks between 34 known highly differentially expressed miRNAs and targets were constructed by mirDIP and Navigator. The predicted targets showed that FAM135A, IKZF2, PLAG1, ZNF148, PHC3, LCOR and DYRK1A, which are associated with cellular differentiation and transcriptional regulation, were recognized by 8 miRNAs or 9 miRNAs through interactional regulatory networks. Seven target genes were confirmed by RT-qPCR. The results showed that the expression of DYRK1A, FAM135A, PLAG1, ZNF148, and PHC3 were obviously inhibited at 3 h, 6 h, and 9 h postinfection. The expression of LCOR did not show a significant change, and the expression of IKZF2 increased gradually with prolonged infection time. Our findings improve the understanding of the pathogenic mechanism of CVB3 infection on cellular differentiation and development through miRNA regulation, which has implications for interventional approaches to CVB3-infection therapy. Our results also provide a new method for screening target genes of microRNA regulation in virus-infected cells.

Subject terms: Virology, Viral host response

Introduction

Enteroviruses include diverse RNA viruses classified in the Picornaviridae family. The genus Enterovirus consists of 15 species, including enteroviruses, polioviruses, coxsackieviruses, rhinoviruses, and echoviruses1. Different species of enterovirus can cause multiple human diseases, such as Poliovirus (PV)-associated infantile paralysis, coxsackievirus B3 (CVB3)-associated myocarditis, enterovirus 71 (EV71) and other enterovirus-associated hand foot and mouth disease, enterovirus 68 (EV68) and rhinovirus-associated respiratory diseases2.

CVB3 is one of the major causative agents of viral myocarditis, which can eventually lead to heart failure and dilated cardiomyopathy, resulting in nearly 50% of heart transplantation in children and young adults3–7. CVB3 also infects the human brain and pancreas and contributes to aseptic meningitis and pancreatitis3. The main pathological processes of viral myocarditis and pancreatitis are early direct virus-induced cytopathic effects and severe inflammatory injury, followed by host immune responses. However, the exact pathogenesis of CVB3 is not fully understood.

MicroRNAs (miRNAs) are a highly conserved class noncoding RNA with a length of approximately 18–25 nucleotides8,9. miRNAs play a key role in regulating cellular development, proliferation, differentiation, cellular growth control and disease progression10,11. Host miRNAs regulate various signal pathways to mediate host–virus interactions during viral infection. Viruses induce the expression of certain cellular miRNAs to interfere with cellular function. miRNAs influence the cellular tropism of viruses, modulate viral infectivity, and induce appropriate antiviral immune responses12–16. The role of regulatory mechanisms of host miRNAs in CVB3–host interactions have been elucidated by several studies. CVB3 infection changes the expression of host miRNAs, which effect viral replication or host cytopathogenesis17. Using an in vitro CVB3 infection model, miR-141, which is activated by early growth response protein 1 (EGR1) as the transcription factor, switches the protein translation initiation pattern through inhibition of eIF4E to benefit viral replication18. Expression of miR-203 promotes CVB3 replication both in vitro and in vivo through inhibition of transcription factor zinc finger protein 148 (ZNF-148), which downregulates genes of cell cycle arrest and upregulate genes of cell growth19. miR-126 promotes the formation and release of viral particles and contributes to viral cytopathogenicity by three specific targets: low-density lipoprotein receptor-related protein 6 (LRP6), sprouty-related, EVH1 domain-containing protein 1 (SPRED1), and Wnt1 responsive Cdc42 homology 1 (WRCH1) of ERK1/2 and Wnt/β-catenin signal pathways20. Additionally, miR-342–5p targets the nonstructural protein 2C region to repress viral replication, while miR-10a* directly binds the CVB3 genome 3D region to benefit CVB3 replication21,22.

Therefore, CVB3 can construct its own survival strategy through regulation of the expression of many specific miRNAs in its own ever-evolving process. The aim of this study was to establish miRNA-regulated networks to identify target genes in HeLa cells infected with CVB3 by small-RNA high-throughput sequencing. Our study also provides new experimental procedures to explore miRNA-regulated target genes by small-RNA high-throughput sequencing.

Results

MicroRNA profile of CVB3 virus-infected cells

A total of 3 × 106 HeLa cells, a human malignant cervical tumor cell line, were inoculated with CVB3 (MOI = 1), cellular miRNA profiles were generated by small-RNA deep-sequencing. A total of 23,267,581, 21,829,256, 22,846,983 and 24,328,282 clean reads were obtained at the three time points and the control HeLa cells using BGISEQ-500 technology, respectively. All clean reads were subjected to sRNA databases, such as miRBase, Rfam, and siRNA, resulting in 2.2 × 107, 2.0 × 107, 2.1 × 107, and 2.2 × 107 miRNA sequence tags in three CVB3 infection time points and cell control, respectively.

Compared with control cells, 970 differentially expressed miRNAs were identified in CVB3-infected cells. We used the ExpDiff method to analyze differentially expressed sRNAs (DESs) between CVB3-infected HeLa cells and normal cells at each infection time point. In this study, 597 differentially expressed miRNAs were found between CVB3-infected HeLa cells and normal HeLa cells from RNA sequencing (RNA-Seq) data. Subsequently, we further compared these 597 miRNAs among three time points and performed hierarchical clustering, as shown in Fig. 1. All differentially expressed miRNAs are shown using hierarchical clustering (Fig. 1).

Figure 1.

Figure 1

Open in a new tab

Hierarchical clustering of differentially expressed miRNAs. Hierarchical clustering was performed using differentially expressed miRNAs between CVB3-infected HeLa cells and normal cells at 3 h, 6 h and 9 h pi. The X axis represents compared miRNAs of each infection time point with normal cells. The Y axis represents DESs. Coloring indicates fold change (upregulated: red, downregulated: blue).

Identification of differentially expressed miRNAs in CVB3-infected HeLa cells

To reduce the range, we further compared these 597 miRNAs among three time points postinfection by >1.5 relative expression change. The expression levels of 68 miRNAs were significantly altered in CVB3-infected HeLa cells compared to uninfected HeLa cells. Of these 68 miRNAs, 51 were highly expressed, including hsa-miR-378i, hsa-miR-518e-3p, hsa-miR-422a, hsa-miR-548au-3p, hsa-miR-20b-3p, hsa-miR-150-5p, hsa-miR-4684-3p, and hsa-miR-548i, which exhibited 5-fold increased expression (Table S2). There were 17 downregulated miRNAs, including hsa-miR-522-5p, hsa-miR-32-5p, and hsa-miR-26a-1-3p (Table S2). There were 38 miRNAs that were newly identified, including novel_mir903, novel_mir898, novel_mir703, novel_mir696, novel_mir351, novel_mir343, and novel_mir334.

To verify the sequencing data, 16 miRNAs in CVB3-infected cells or normal cells were detected by RT-qPCR using TaqMan miRNA assays. RT-qPCR results were consistent with the results from sequencing data (Table S3). The high correlation between the sequencing results and RT-qPCR detection confirmed that the tested miRNAs were reproducible. The findings showed that differentially expressed miRNAs identified by small-RNA sequencing accurately reflected the miRNA content in CVB3-infected cells or normal cells.

Analysis of Gene Ontology (GO) categories of DESs Target

To further understand the biological implications of differently expressed miRNAs, target genes of 68 miRNAs were predicted in gene term enrichment analysis using Gene Ontology (GO) categories. The analysis results showed that the predicted target genes contained the top three enriched biological processes: cellular process, regulation of biological process, single-organism process, metabolic process, and biological regulation. Within the category “cellular component”, the largest number of predicted target genes were involved in cell function, cell part, organelle and membrane function. Regarding the category “molecular function”, the predicted target genes were mainly associated with molecular transducer, catalytic activity and protein binding.

Analysis of KEGG (Kyoto Encyclopedia of Genes and Genomes) Pathway Enrichment of DES Targets

After GO functional classification analysis, we performed pathway enrichment analysis of DES target genes based on the KEGG database and generated a report for DES target genes in each pairwise comparison. Our analysis showed that the top three were successively Signal Transduction, Global and overview maps, and Cancers. The top three parts were successively Global and overview maps, Nucleotide metabolism, Carbohydrate metabolism in Metabolism; Sorting and Degradation, Translation, Transcription in Genetic Information Processing; Cellular community, Transport and catabolism, Cell growth and death in Cellular Processes; Immune system, Endocrine system, Digestive system in Organismal Systems; Infectious Diseases and Cancers in Human Diseases; and Membrane Transport, Signal Transduction, Signaling Molecules and Interaction in Environmental Information Processing. KEGG pathway and GO category analysis demonstrated that the interaction of the target miRNAs was associated with many physiological processes.

Prediction and confirmation of targets for multiple mirnas

Next, interaction networks between 34 known differentially expressed miRNAs (Table S4) and targets were established by mirDIP and Navigator23,24. We filtered and deleted those targets interacting with 1–3 miRNAs, and the target genes were identified by those regulated by 4 miRNAs or more, including hsa-miR-663a, hsa-miR-548j-5p, hsa-miR-548i, hsa-miR-548au-3p, hsa-miR-4694-3p, hsa-miR-378i, hsa-miR-378d, hsa-miR-374b-5p, hsa-miR-374b-3p, hsa-miR-32-5p, hsa-miR-3184-5p, hsa-miR-26a-2-3p, hsa-miR-218-2-3p, hsa-miR-150-5p, hsa-miR-125b-2-3p, and hsa-miR-125p. In concentric ellipses, the targets were recognized by 4, 5, 6, 7, 8 and 9 miRNAs (Fig. 2). The predicted results showed that FAM135A, IKZF2, PLAG1, ZNF148, PHC3 and LCOR were regulated by 8 miRNAs (Fig. 2, blue circles) and DYRK1A was regulated by 9 miRNAs (Fig. 2, purple circle).

Figure 2.

Figure 2

Open in a new tab

Construction of the miRNA-target network. Interaction networks between 34 known differentially expressed miRNAs and targets were established by mirDIP and Navigator. After filtration of those targets interacting with 1–3 miRNAs, targets recognized by 4 miRNAs or more were constructed into miRNA-target networks. In concentric ellipses, the targets were regulated by 4, 5, 6, 7, 8 and 9 miRNAs (deep purple circles, orange circles, light green circles, green circles, blue circles, purple circles, respectively).

To verify the predicted results, the expression of the above 7 genes was detected by RT-qPCR from uninfected or CVB3-infected cells at 3 h, 6 h, and 9 h (pi). The results showed that DYRK1A, FAM135A, PLAG1, ZNF148, and PHC3 were obviously inhibited at infection times of 3 h, 6 h, and 9 h pi (Fig. 3). There was no change in LCOR mRNA levels at each infection time point. However, the expression of IKZF2, which was recognized by 9 miRNAs (Fig. 2 purple circle), increased gradually with the prolongation of the infection time (Fig. 3).

Figure 3.

Figure 3

Open in a new tab

RT-qPCR validation of predicted target genes. DYRK1A, FAM135A, PLAG1, ZNF148, PHC3, LCOR and IKZF2 target genes were confirmed by RT-qPCR. Approximately 1.5 × 104 cells were incubated for 12 h prior to infection with CVB3 (MOI = 1). After infected or uninfected cells of three repetitive wells were collected at 3 h, 6 h, and 9 h pi, isolation of total cellular RNA and RT-qPCR of each well was performed successively. Data normalization was performed using actin mRNA as an endogenous control. The relative amount of target mRNA was calculated by the log2 conversion of 2−ΔΔCt. Compared in two groups, significant differences were marked as *P < 0.05.

Discussion

Many studies have shown that miRNAs are key effector molecules during interactions between viruses and hosts12,13,25. To identify specific miRNAs involved in the cellular response of CVB3, miRNA profiles in CVB3-infected HeLa cells were generated.

In this study, a total of 597 differentially expressed miRNAs were identified across three time points in CVB3-infected HeLa cells; among them, both common and unique miRNAs were identified, indicating that expression of miRNA is complex during CVB3 virus infection. The 68 miRNAs and 34 novel miRNAs showed similar trends and indicated that these miRNAs simultaneously participated in interactions with host cells. The identified cellular miRNAs in infected cells can regulate many signal pathways to disturb viral replication from some reports, though we did not knock out these miRNAs to observe viral replication. Some of these miRNAs may be potential candidates for antiviral therapeutic or prophylactic targets.

Many reports show that viral infections can reshape the expression of cellular miRNAs, thereby affecting the microenvironment and metabolism of cells and ultimately leading to the pathogenesis of the virus. In this study, a total of 68 differentially expressed miRNAs were screened from RNA sequencing data. Then, we focused on functional studies from these known miRNAs. GO and KEGG analysis found that several biological processes were significantly related to cellular component, molecular function, biological process, etc., indicating that these differentially expressed miRNAs may be associated with CVB3 infection.

Then, 34 miRNAs were selected to construct miRNA-Target interactional networks by mirDIP and Navigator. The results showed that 7 target genes, including FAM135A, IKZF2, PLAG1, ZNF148, PHC3, LCOR and DYRK1A, were regulated by 8 miRNAs or 9 miRNAs. These genes are closely related to the regulation of cellular proliferation, differentiation, development and cellular growth control. The above results showed that CVB3 infection induced cellular miRNAs to regulate multiple cellular processes, which are important modulators of cellular proliferation, differentiation and development26–30.

CVB3 infection induced downregulation of DYRK1A and FAM135A, which are associated with neural system development. DYRK1A, as a member of the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) family, mainly regulates a signaling pathway of cell proliferation and differentiation of neuronal progenitor cells31. DYRK1A also activates the nuclear factor of activated T-cells (NFAT) to regulate HIV-1 transcription through NFAT nucleus translocation32. NFAT activation is also crucial to CVB3-induced myocarditis susceptibility33. Some research still shows that DYRK kinases play an important regulatory role in Herpesvirus replication. DYRK1A can significantly inhibit the replication of many Herpes viruses, such as HCMV, HSV-1, VZV and RhCMV, through either knockdown of DYRK1A or DYRK inhibitors34,35. Thus, we speculate that downregulated DYRK1A cannot promote CVB3 replication in this study, though further experimentation needs to be confirmed.

Although previous studies evaluated the biological relevance of Fam135a in the effects of ethanol on anxiety36, Fam135a has been shown to be differentially expressed in the amygdala, hypothalamus, pituitary, hippocampus, ventral tegmental area (VTA), and adrenal gland pituitary gland in mice37 and indicated that FAM135A is associated with neural system development. However, there is no report that FAM135A directly affects viral replication or participates in CVB3-infected pathophysiology.

Thus, our results may explain why CVB3 infection induces many miRNAs to inhibit the expression of DYRK1A and FAM135A, prevent neurodevelopment, and reduce cognitive function or severe neurological complications. This may be one of the important reasons for pathological changes in the nervous system caused by enterovirus.

miRNAs also participate and stabilize myogenesis, hematopoiesis, and neural development through regulation of gene transcription38. Zinc finger protein 148 (ZNF148, or ZFP-148), a Krüppel-type zinc finger transcription factor, is universally expressed in nearly all mammalian cells39. Multifunctional ZNF148 is involved in the regulation of upstream signaling pathways of cellular proliferation, apoptosis and embryogenesis40,41. To date, more than 30 target genes for ZNF148 have been identified, many of which can be associated with the clinical phenotypes observed in patients42. ZNF-148 also binds with miRNA to regulate CVB3 replication and pathogenicity19,43. A study showed that CVB3 replication increased in HeLa cells after ZNF148 was inhibited by miR-20319. Similarly, CVB3 infection also induced the upregulation of miR-20b to inhibit the expression of ZNF148 in CVB3-infected BALB/c mouse heart tissues43. Our results further confirmed that CVB3 infection induced many miRNAs to repress the expression of the transcriptional factors ZNF148.

Pleomorphic adenoma gene 1 (PLAG1), a member of the PLAG family of zinc finger transcription factors, changes the target gene transcription rate to regulate the expression of target genes. Regulation of Insulin-like growth factor-2 (IGF2) transcription to effect mTORC1 activity44 is the most important. PLAG1 also adjusts the transcription of the signal molecule of the Wnt pathway, regulators of the cell cycle, and immunomodulatory factors45,46. PLAG1 still stabilizes hematopoietic stem and progenitor cells (HSPCs)47. Abnormal misexpression of both PLAG1 and PLAGl2 appeared in acute myeloid leukemia-induced amphotropic murine leukemia virus (MLV) strain 4070A48. In combination with the above reports, CVB3 infection may break cellular signal transduction through inhibition of PLAG1, a topic that is important in future research.

CVB3 infection also inhibited the expression of transcriptional regulators such as polyhomeotic homolog 3 (PHC 3), which is a ubiquitous member of the human Polycomb complex49. PHC3 binds with the transcription factor E2F6 as a Polycomb complex to silence promoters of target genes to prevent cell cycle progression. Several studies have shown that proteins of some viruses may subvert a critical cellular defense mechanism through E2F6. In addition to simian virus 40 T antigen and adenovirus E1A, HPV E7 proteins inhibit the formation of Polycomb complexes to inactivate the transcriptional repression activity of E2F650, resulting in the prolonged S-phase in HPV-infected cells. EBNA3C binds with the amino and carboxy termini of E2F6 to competitively inhibit the formation of E2F6/Polycomb complexes. Then, E2F6 is taken by EBNA3C to the E2F1 promoter to promote cell proliferation51.

Ligand-dependent corepressor (LCoR), as a regulator of nuclear receptor transactivation, binds histone deacetylases and C-terminal binding proteins (CtBP) to repress target gene transcription52–54. However, until now, there has been no report on the effect of LCoR on viral replication and pathogenesis, though expression of LCoR showed no significant change by RT-qPCR in this study.

Thus, CVB3 infection may induce HeLa cellular miRNA to inhibit the above transcriptional factors and transcriptional regulators to inhibit cell proliferation and development, though further studies will be explored in animal models.

miRNAs play a posttranscriptional regulatory role through targeting the 3′-untranslated region (UTR) of mRNA to cause mRNA degradation or translation repression10,11. However, many studies have shown that miRNAs induce gene activation by binding long non-coding RNAs (lncRNAs) or promoter-associated RNAs (pRNAs) or the transcriptional activator complex55. Our results indicated that CVB3 infection may induce miRNA-guided transcriptional gene IKZF2 activation. IKZF2 (known as Helios), a member of the Ikaros family of Krüppel-like zinc finger proteins, plays a key role in the differentiation and activation of T cell functions56,57. IKZF2 is also associated with the regulation of inflammatory and immune responses58,59. To a certain extent, the IKZF2 protein still stabilizes regulatory T-cells (Tregs) suppressive function in the face of inflammatory responses regulatory60,61. Tregs, which express highly suppressive IKZF2, may be conducive to control of HIV replication62. Thus, it is possible that CVB3 infection boosts Treg cell function to inhibit both TFH (Follicular helper T cell) and Th1 effector cell responses through IKZF2. These may also be an important mechanism of enterovirus pathogenesis and destruction of immune responses influenced by miRNAs, though further studies are needed.

In this study, a new method for screening target genes of microRNA regulation was established in viral-infected cells by small-RNA high-throughput sequencing. In contrast to the previous study, we used highly differentially expressed microRNAs to construct a microRNA-Target interactional network through known microRNA databases. Using this network, we found that many target genes were recognized simultaneously by multiple microRNAs, and then the expression of these genes was identified by RT-qPCR detection. Six genes were identified to have significantly differential expression using this method. Our results further confirm that the expression of ZNF148 was repressed by microRNA during CVB3 infection, as previously reported19,43. Downregulation of 4 miRNA target genes, including PLAG1, ZNF148, PHC3, and DYRK1A, was first found in CVB3-infected cells, though 4 genes were associated with nonenterovirus replication and infection. We also found that the expression of FAM135A was significantly inhibited in CVB3-infected HeLa cells.

In conclusion, miRNA expression profiles and specific interactional networks were constructed in CVB3-infected HeLa cells by small-RNA sequencing technology in this study. Seven target genes, including FAM135A, IKZF2, PLAG1, ZNF148, PHC3, LCOR and DYRK1A, were recognized by 8 miRNAs or 9 miRNAs through miRNA-Target interactional networks. The RT-qPCR results showed that the expression of DYRK1A, FAM135A, PLAG1, ZNF148, and PHC3 was obviously inhibited at 3 h, 6 h, and 9 h pi. However, the expression of LCOR did not show a significant change, and the expression of IKZF2 increased with the prolongation of infection time in this study. Though our results are fairly limited and require extensive exploration on cardiomyocytes and animal model, this study will provide some information for miRNA-mediated regulatory mechanisms during enterovirus infection.

Methods

Cell & virus

HeLa cells were propagated in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) (GIBCO, Thermofisher, USA), 100 u/ml penicillin, and 100 μg/ml streptomycin at 37 °C. CVB3 M strain (MOI = 1) was propagated in HeLa cells with 2% FBS at 37 °C as in a previous study63,64.

RNA isolation

Total RNA from 4 samples of CVB3-infected HeLa cells at 3 h, 6 h and 9 h pi and uninfected HeLa cells was isolated using TRIzol reagent (Thermofisher, USA) according to the manufacturer’s instructions. The enrichment of the miRNA fraction was performed using the PureLink miRNA Isolation Kit (Invitrogen, USA). RNA samples were subjected to construct the sequencing library. After the library was constructed, the quality of the library was assessed using a Bioanalyzer 2100 before carrying out NGS. A substantial amount of sRNA sequences (16-30 nt) were obtained after removal of linkers and low-quality data. After performing quality control, 4 samples with an optimal quality profile were prepared for NGS.

Next-generation sequencing

Small-RNA sequencing using BGISEQ-500 technology was performed by BGI Co., Ltd, China. To obtain highly reliable sequencing data, strict quality control in each experiment step was carried out. After obtaining raw data, trimming was performed to remove adaptor sequences. Then, the miRNAs were annotated using the miRBase platform (release 20.0, Homo sapiens). The expression level of miRNAs was calculated using TPM (Transcripts Per Kilobase Million)65. The 49 nt sequence tags from HiSeq sequencing were first generated using data cleaning analysis to obtain credible clean tags. The clean tags were annotated into known miRNA categories, and no annotated tags were used to predict the novel miRNA. The differentially expressed miRNA was calculated by the log2 conversion of TPM ratio between infected cells and control cells.Hierarchical clustering of differentially expressed sRNAs (DESs) was performed. After obtaining similar changes in miRNA at 3 h, 6 h and 9 h pi, the biological processes of GO enrichment and KEGG pathway were analyzed using WEGO software and KEGG database.

Generation of predicted miRNA-transcript interaction networks

Thirty-four miRNAs induced by CVB3 infection were input into the microRNA Data Integration Portal66,67. Interaction networks were generated using target genes identified by miRDIP. The visualized networks between miRNAs and their predicted mRNA targets were constructed using NAViGaTOR v2.1423,68,69.

Reverse transcription quantitative PCR (RT-qPCR)

The expression level of 16 randomly selected miRNAs was confirmed using miRNA-specific RT-qPCR assays. Briefly, after 4 samples were collected as described above, 500 ng of total cellular RNA from each sample was reverse transcribed using the TaqMan microRNA Reverse Transcription Kit (Applied Biosystems) according to the manufacturer’s instructions. qPCR was carried out on a 7500 FAST Real-Time PCR System. Each sample was repeated three times. Data normalization was performed using U6 mRNA as an endogenous control. The relative amount of target mRNA was calculated by the log2 conversion of 2−ΔΔCt.

Based on the predicted target genes recognized by 8-9 miRNAs, target genes, including DYRK1A, FAM135A, PLAG1, ZNF148, PHC3, LCOR and IKZF2, were confirmed by RT-qPCR using a real-time PCR system (CFX96, USA). After approximately 1.5 × 104 cells were incubated in each well of a 96-well cell plate for 12 h, HeLa cells were inoculated with CVB3 (MOI = 1). After infected or uninfected cells of three repetitive wells were collected at 3 h, 6 h, and 9 h pi, total cellular RNA of each well was isolated with TRIzol reagent (Invitrogen™, USA) according to the manufacturer’s instructions. RT-qPCR was performed using the One Step SYBR®PrimeScriptTM PLUS RT-PCR Kit (TAKARA, Japan) according to the manufacturer’s recommendations. RT-qPCR cycling was performed at 95 °C for 10 s, followed by 30 s at 95 °C and 30 s at 60 °C for 40 cycles. All gene primers are listed in Table S1. Data normalization was performed using actin mRNA as an endogenous control. The relative amount of target mRNA was calculated by the log2 conversion of 2−ΔΔCt.

Statistics

Significant variability among the mean values (±standard deviations (SD)) of the experimental groups was determined by paired Student’s t test using SPSS 10.0 software (SPSS, Inc., Chicago, IL, USA). The differences were considered statistically significant at P < 0.05.

Supplementary information

Supplementary information (115KB, pdf)

Acknowledgements

We appreciate assistance from Dr. Francisco J. Enguita of Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal for miRNA-target networks. This work was supported by the China Mega-Project for Infectious Disease [Grant Numbers 2018ZX10102001, 2018ZX10711001, and 2018ZX10734404] and the SKLID Development Grant [Grant Number 2011SKLID104].

Author contributions

J.H. conceived and designed the experiments. H.L.Y., M.L., W.J.W. and X.L.W. performed the experiments. J.H., H.L.Y. and M.L. analyzed the data. J.S. and Q.Q.S. contributed reagents/materials/analysis tools. J.H. and H.L.Y. wrote the paper.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Hai Lan Yao and Mi Liu.

Supplementary information

is available for this paper at 10.1038/s41598-019-54188-w.

References

  • 1.Zell R, et al. ICTV Virus Taxonomy Profile: Picornaviridae. The Journal of general virology. 2017;98:2421–2422. doi: 10.1099/jgv.0.000911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Xiao X, Qi J, Lei X, Wang J. Interactions Between Enteroviruses and the Inflammasome: New Insights Into Viral Pathogenesis. Frontiers in microbiology. 2019;10:321. doi: 10.3389/fmicb.2019.00321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Liu H, Li M, Song Y, Xu W. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production. Frontiers in immunology. 2018;9:2479. doi: 10.3389/fimmu.2018.02479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annual review of pathology. 2008;3:127–155. doi: 10.1146/annurev.pathmechdis.3.121806.151534. [DOI] [PubMed] [Google Scholar]
  • 5.Tam PE. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral immunology. 2006;19:133–146. doi: 10.1089/vim.2006.19.133. [DOI] [PubMed] [Google Scholar]
  • 6.Sagar S, Liu PP, Cooper LT., Jr. Myocarditis. Lancet (London, England) 2012;379:738–747. doi: 10.1016/s0140-6736(11)60648-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Gaaloul I, et al. Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients. Molecular medicine reports. 2014;10:2811–2818. doi: 10.3892/mmr.2014.2578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science (New York, N.Y.) 2001;294:853–858. doi: 10.1126/science.1064921. [DOI] [PubMed] [Google Scholar]
  • 9.Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–854. doi: 10.1016/0092-8674(93)90529-Y. [DOI] [PubMed] [Google Scholar]
  • 10.Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. doi: 10.1016/S0092-8674(04)00045-5. [DOI] [PubMed] [Google Scholar]
  • 11.Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003;113:673–676. doi: 10.1016/S0092-8674(03)00428-8. [DOI] [PubMed] [Google Scholar]
  • 12.Cullen BR. MicroRNAs as mediators of viral evasion of the immune system. Nature immunology. 2013;14:205–210. doi: 10.1038/ni.2537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kelly EJ, Hadac EM, Cullen BR, Russell SJ. MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference. PLoS pathogens. 2010;6:e1000820. doi: 10.1371/journal.ppat.1000820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lee S, et al. Selective degradation of host MicroRNAs by an intergenic HCMV noncoding RNA accelerates virus production. Cell host & microbe. 2013;13:678–690. doi: 10.1016/j.chom.2013.05.007. [DOI] [PubMed] [Google Scholar]
  • 15.Li Y, Masaki T, Lemon SM. miR-122 and the Hepatitis C RNA genome: more than just stability. RNA biology. 2013;10:919–923. doi: 10.4161/rna.25137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Umbach JL, Cullen BR. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes & development. 2009;23:1151–1164. doi: 10.1101/gad.1793309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Garmaroudi FS, et al. Coxsackievirus B3 replication and pathogenesis. Future microbiology. 2015;10:629–653. doi: 10.2217/fmb.15.5. [DOI] [PubMed] [Google Scholar]
  • 18.Ho BC, et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell host & microbe. 2011;9:58–69. doi: 10.1016/j.chom.2010.12.001. [DOI] [PubMed] [Google Scholar]
  • 19.Hemida MG, et al. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148. Cellular and molecular life sciences: CMLS. 2013;70:277–291. doi: 10.1007/s00018-012-1104-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ye X, et al. MiR-126 promotes coxsackievirus replication by mediating cross-talk of ERK1/2 and Wnt/beta-catenin signal pathways. Cellular and molecular life sciences: CMLS. 2013;70:4631–4644. doi: 10.1007/s00018-013-1411-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tong L, et al. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic acids research. 2013;41:3760–3771. doi: 10.1093/nar/gkt058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wang L, et al. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Antiviral research. 2012;93:270–279. doi: 10.1016/j.antiviral.2011.12.004. [DOI] [PubMed] [Google Scholar]
  • 23.Jurisica, I et al. NAViGaTOR, http://ophid.utoronto.ca/navigator, (2018).
  • 24.Leitao AL, Costa MC, Enguita FJ. A guide for miRNA target prediction and analysis using web-based applications. Methods in molecular biology (Clifton, N.J.) 2014;1182:265–277. doi: 10.1007/978-1-4939-1062-5_23. [DOI] [PubMed] [Google Scholar]
  • 25.Trobaugh DW, Klimstra WB. MicroRNA Regulation of RNA Virus Replication and Pathogenesis. Trends in molecular medicine. 2017;23:80–93. doi: 10.1016/j.molmed.2016.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gangaraju VK, Lin H. MicroRNAs: key regulators of stem cells. Nature reviews. Molecular cell biology. 2009;10:116–125. doi: 10.1038/nrm2621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Guedes J, Cardoso AL, Pedroso de Lima MC. Involvement of microRNA in microglia-mediated immune response. Clinical & developmental immunology. 2013;2013:186872. doi: 10.1155/2013/186872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gurtan AM, Sharp PA. The role of miRNAs in regulating gene expression networks. Journal of molecular biology. 2013;425:3582–3600. doi: 10.1016/j.jmb.2013.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Shen C, Houghton PJ. The mTOR pathway negatively controls ATM by up-regulating miRNAs. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:11869–11874. doi: 10.1073/pnas.1220898110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Swaminathan G, Martin-Garcia J, Navas-Martin S. RNA viruses and microRNAs: challenging discoveries for the 21st century. Physiological genomics. 2013;45:1035–1048. doi: 10.1152/physiolgenomics.00112.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tejedor FJ, Hammerle B. MNB/DYRK1A as a multiple regulator of neuronal development. The FEBS journal. 2011;278:223–235. doi: 10.1111/j.1742-4658.2010.07954.x. [DOI] [PubMed] [Google Scholar]
  • 32.Booiman T, et al. DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner. PloS one. 2015;10:e0144229. doi: 10.1371/journal.pone.0144229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Huber SA, Rincon M. Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibility. Virology. 2008;381:155–160. doi: 10.1016/j.virol.2008.08.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bol SM, et al. Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages. PloS one. 2011;6:e17190. doi: 10.1371/journal.pone.0017190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hutterer C, et al. Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity. Antiviral research. 2017;143:113–121. doi: 10.1016/j.antiviral.2017.04.003. [DOI] [PubMed] [Google Scholar]
  • 36.Cook MN, et al. Identification of candidate genes that underlie the QTL on chromosome 1 that mediates genetic differences in stress-ethanol interactions. Physiological genomics. 2015;47:308–317. doi: 10.1152/physiolgenomics.00114.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Malki K, et al. Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. Biological psychiatry. 2011;69:360–365. doi: 10.1016/j.biopsych.2010.08.011. [DOI] [PubMed] [Google Scholar]
  • 38.Shenoy A, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nature reviews. Molecular cell biology. 2014;15:565–576. doi: 10.1038/nrm3854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Merchant JL, et al. ZBP-89, a Kruppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Molecular and cellular biology. 1996;16:6644–6653. doi: 10.1128/MCB.16.12.6644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gao XH, et al. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray. Cancer. 2013;119:2212–2222. doi: 10.1002/cncr.28052. [DOI] [PubMed] [Google Scholar]
  • 41.Ye CG, et al. Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma. Biochimica et biophysica acta. 2013;1833:2970–2979. doi: 10.1016/j.bbamcr.2013.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hahn S, Hermeking H. ZNF281/ZBP-99: a new player in epithelial-mesenchymal transition, stemness, and cancer. Journal of molecular medicine (Berlin, Germany) 2014;92:571–581. doi: 10.1007/s00109-014-1160-3. [DOI] [PubMed] [Google Scholar]
  • 43.Xu HF, et al. MicroRNA-20b suppresses the expression of ZFP-148 in viral myocarditis. Molecular and cellular biochemistry. 2017;429:199–210. doi: 10.1007/s11010-017-2947-7. [DOI] [PubMed] [Google Scholar]
  • 44.Chen KS, et al. Mutations in microRNA processing genes in Wilms tumors derepress the IGF2 regulator PLAG1. Genes & development. 2018;32:996–1007. doi: 10.1101/gad.313783.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Voz ML, et al. Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene. 2004;23:179–191. doi: 10.1038/sj.onc.1207013. [DOI] [PubMed] [Google Scholar]
  • 46.Declercq J, Van Dyck F, Van Damme B, Van de Ven WJ. Upregulation of Igf and Wnt signalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice. International journal of oncology. 2008;32:1041–1047. [PubMed] [Google Scholar]
  • 47.Belew MS, et al. PLAG1 and USF2 Co-regulate Expression of Musashi-2 in Human Hematopoietic Stem and Progenitor Cells. Stem cell reports. 2018;10:1384–1397. doi: 10.1016/j.stemcr.2018.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Castilla LH, et al. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:4924–4929. doi: 10.1073/pnas.0400930101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Iwata S, et al. Polycomb group molecule PHC3 regulates polycomb complex composition and prognosis of osteosarcoma. Cancer science. 2010;101:1646–1652. doi: 10.1111/j.1349-7006.2010.01586.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.McLaughlin-Drubin ME, Huh KW, Munger K. Human papillomavirus type 16 E7 oncoprotein associates with E2F6. Journal of virology. 2008;82:8695–8705. doi: 10.1128/jvi.00579-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Pei Y, et al. EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation. PLoS pathogens. 2016;12:e1005844. doi: 10.1371/journal.ppat.1005844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Jalaguier S, et al. Complex regulation of LCoR signaling in breast cancer cells. Oncogene. 2017;36:4790–4801. doi: 10.1038/onc.2017.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.White JH, Fernandes I, Mader S, Yang XJ. Corepressor recruitment by agonist-bound nuclear receptors. Vitamins and hormones. 2004;68:123–143. doi: 10.1016/s0083-6729(04)68004-6. [DOI] [PubMed] [Google Scholar]
  • 54.Calderon MR, et al. Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene. The Journal of biological chemistry. 2012;287:8662–8674. doi: 10.1074/jbc.M111.311605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Matsui M, et al. Promoter RNA links transcriptional regulation of inflammatory pathway genes. Nucleic acids research. 2013;41:10086–10109. doi: 10.1093/nar/gkt777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Georgopoulos K, Winandy S, Avitahl N. The role of the Ikaros gene in lymphocyte development and homeostasis. Annual review of immunology. 1997;15:155–176. doi: 10.1146/annurev.immunol.15.1.155. [DOI] [PubMed] [Google Scholar]
  • 57.Kelley CM, et al. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Current biology: CB. 1998;8:508–515. doi: 10.1016/S0960-9822(98)70202-7. [DOI] [PubMed] [Google Scholar]
  • 58.Akhabir L, Sandford A. Genetics of interleukin 1 receptor-like 1 in immune and inflammatory diseases. Current genomics. 2010;11:591–606. doi: 10.2174/138920210793360907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Singh RK, Gupta S, Dastidar S, Ray A. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology. 2010;85:336–349. doi: 10.1159/000312669. [DOI] [PubMed] [Google Scholar]
  • 60.Kim HJ, et al. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science (New York, N.Y.) 2015;350:334–339. doi: 10.1126/science.aad0616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Sebastian M, et al. Helios Controls a Limited Subset of Regulatory T Cell Functions. Journal of immunology (Baltimore, Md.: 1950) 2016;196:144–155. doi: 10.4049/jimmunol.1501704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Matavele Chissumba R, et al. Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection. BMC immunology. 2017;18:50. doi: 10.1186/s12865-017-0235-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Yao HL, et al. Gene expression analysis during recovery process indicates the mechanism for innate immune injury and repair from Coxsackievirus B3-induced myocarditis. Virus research. 2016;213:314–321. doi: 10.1016/j.virusres.2016.01.003. [DOI] [PubMed] [Google Scholar]
  • 64.Song QQ, et al. Coxsackievirus B3 2A protease promotes encephalomyocarditis virus replication. Virus research. 2015;208:22–29. doi: 10.1016/j.virusres.2015.05.020. [DOI] [PubMed] [Google Scholar]
  • 65.Mestdagh P, et al. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic acids research. 2008;36:e143. doi: 10.1093/nar/gkn725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Shirdel EA, Xie W, Mak TW, Jurisica I. NAViGaTing the micronome–using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs. PloS one. 2011;6:e17429. doi: 10.1371/journal.pone.0017429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Jurisica, I et al. mirDIP:microRNA Data Integration Portal, http://ophid.utoronto.ca/mirDIP/ (2018).
  • 68.Brown KR, et al. NAViGaTOR: Network Analysis, Visualization and Graphing Toronto. Bioinformatics (Oxford, England) 2009;25:3327–3329. doi: 10.1093/bioinformatics/btp595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.McGuffin MJ, Jurisica I. Interaction techniques for selecting and manipulating subgraphs in network visualizations. IEEE transactions on visualization and computer graphics. 2009;15:937–944. doi: 10.1109/tvcg.2009.151. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary information (115KB, pdf)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES